Who is sponsoring NCT04047537?

NCT04047537 is sponsored by Pendulum Therapeutics.

What drugs are being tested in NCT04047537?

Interventions in NCT04047537: Medical Food Formulation 1, Medical Food Formulation 2, Placebo.

What condition does NCT04047537 study?

NCT04047537 studies Type 2 Diabetes Mellitus.

Is NCT04047537 still recruiting?

NCT04047537 is currently terminated. Last updated 6 May 2022.

Last reviewed 2022-05-06 · How we verify

NCT04047537

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes

Terminated NA Last updated 6 May 2022

What this trial tests

NA trial testing Medical Food Formulation 1 in Type 2 Diabetes Mellitus in 41 participants. Terminated before completion.

Timeline

6 August 2019

Primary endpoint
15 April 2020

30 May 2020

Quick facts

Lead sponsor	Pendulum Therapeutics
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	41
Start date	6 August 2019
Primary completion	15 April 2020
Estimated completion	30 May 2020
Sites	1 location across Ireland

Drugs / interventions tested

Medical Food Formulation 1
Medical Food Formulation 2
Placebo

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →

Sponsor

Pendulum Therapeutics

Who can join

Adults 18 to 75, any sex, with Type 2 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This 12 week placebo-controlled study evaluates the safety and impact of 2 different strengths of the medical food formulation WBF-0011.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Pendulum Therapeutics trials

Trials by the same sponsor.

NCT04424888 — Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study · NA · completed
NCT03893422 — Placebo-Controlled Clinical Nutrition Study of the Safety and Metabolic Effects of Two Medical Foods in Type 2 Diabetes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04047537 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pendulum Therapeutics
Last refreshed: 6 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04047537.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing